Clinical

Dataset Information

0

Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer


ABSTRACT: The purpose of this research study is to learn whether panitumumab helps treat colorectal cancer in participants who have not responded to treatment with cetuximab. Panitumumab is a human monoclonal antibody. Antibodies are proteins that recognize a foreign substance in the body and then attach themselves to it making it exposed to destruction. Panitumumab attaches itself to a protein on cancer cells called "epidermal growth factor receptor" or EGFR. EGFR helps cancer cells to grow, and blocking EGFR helps prevent cancer cells from growing.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2067836 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2016-05-05 | E-MTAB-3548 | biostudies-arrayexpress
2013-11-18 | GSE50119 | GEO
2013-11-18 | GSE50121 | GEO
2013-11-18 | GSE50123 | GEO
2014-01-22 | GSE50120 | GEO
2013-11-18 | GSE50122 | GEO
| 2030413 | ecrin-mdr-crc
| 2720998 | ecrin-mdr-crc
2013-11-18 | E-GEOD-50119 | biostudies-arrayexpress
2014-01-22 | E-GEOD-50120 | biostudies-arrayexpress